[Federal Register Volume 67, Number 149 (Friday, August 2, 2002)]
[Notices]
[Page 50442]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-19512]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel: Interventional Epidemiologic Research Studies To Reduce 
Mother-to-Child HIV-1 Transmission and Improve Infant Survival in 
Resource-Limited Countries of High HIV-1 Seroprevalence, Program 
Announcement 02074

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting:
    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP): Interventional Epidemiologic Research 
Studies to Reduce Mother-to-Child HIV-1 Transmission and Improve Infant 
Survival in Resource-Limited Countries of High HIV-1 Seroprevalence, 
Program Announcement 02074.
    Times and Dates: 9 a.m.-9:30 a.m., August, 28, 2002 (Open) 9:30 
a.m.-4:30 p.m., August 28, 2002 (Closed).
    Place: Double Tree Hotel, 3342 Peachtree Road, NE, Atlanta, GA.
    Status: Portions of the meeting will be closed to the public in 
accordance with provisions set forth in section 552b(c) (4) and (6), 
Title 5 U.S.C., and the Determination of the Director, Management 
Analysis and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to PA# 
02074.
    Contact Person for More Information: Beth Wolfe, Prevention Support 
Office, National Center for HIV, STD, and TB Prevention, CDC, 1600 
Clifton Road NE MS E-07, Atlanta, Georgia 30333, 404-639-8025.
    The Director, Management Analysis and Services Office has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

    Dated: July 29, 2002.
John Burckhardt,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 02-19512 Filed 8-1-02; 8:45 am]
BILLING CODE 4163-18-P